计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| P651739-5mg |
5mg |
期货 ![]() |
| |
| P651739-10mg |
10mg |
期货 ![]() |
| |
| P651739-25mg |
25mg |
期货 ![]() |
| |
| P651739-50mg |
50mg |
期货 ![]() |
| |
| P651739-100mg |
100mg |
期货 ![]() |
|
| 规格或纯度 | ≥99% |
|---|---|
| 英文名称 | PI3Kδ-IN-1 |
| 生化机理 | PI3Kδ-IN-1 是一种强效、选择性和高效的 PI3Kδ 抑制剂,其 IC 50 为 1.7 nM。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 产品介绍 |
PI3Kδ-IN-1 is a potent, selective, and efficacious PI3Kδ inhibitor with an IC 50 of 1.7 nM. In Vitro PI3Kδ-IN-1 (compound 52) shows >100-fold selectivity over the other PI3K isoforms. Kinome selectivity is also excellent with >660-fold selectivity over MNK1 and others in HTRF assays. Importantly, PI3Kδ-IN-1 has an improved human/rodent in vitro stability correlation and a good permeability profile. MCE has not independently confirmed the accuracy of these methods. They are for reference only. In Vivo PI3Kδ-IN-1 (2, 5 mg/kg, orally b.i.d. for 42 days) shows greater than 50% suppression of paw swelling in mice. PI3Kδ-IN-1 has an EC 50 of 10 nM at 24 h ( ED 50 of ∼1.25 mg/kg) in mice . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male DBA/1 mice (20−25g) Dosage: 0.5, 2, 5 mg/kg Administration: Oral b.i.d. for 42 days, Result: A dose dependent reduction of the clinical score was observed. Doses of 2 and 5 mg/kg showed greater than 50% suppression of paw swelling . Form:Solid IC50& Target:IC50: 1.7 nM (PI3Kδ) |
| 纯度 | ≥99% |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IIUPAC Name | 2-(4-acetyl-3,3-dimethyl-2-oxopiperazin-1-yl)-4-[4-amino-5-(trifluoromethyl)pyrrolo[2,1-f][1,2,4]triazin-7-yl]benzonitrile |
| INCHI | 1S/C22H20F3N7O2/c1-12(33)31-7-6-30(20(34)21(31,2)3)16-8-13(4-5-14(16)10-26)17-9-15(22(23,24)25)18-19(27)28-11-29-32(17)18/h4-5,8-9,11H,6-7H2,1-3H3,(H2,27,28,29) |
| InChi Key | ZDXIDBRGTYDHBQ-UHFFFAOYSA-N |
| Smiles | CC(=O)N1CCN(C(=O)C1(C)C)C2=C(C=CC(=C2)C3=CC(=C4N3N=CN=C4N)C(F)(F)F)C#N |
| Isomeric SMILES | CC(=O)N1CCN(C(=O)C1(C)C)C2=C(C=CC(=C2)C3=CC(=C4N3N=CN=C4N)C(F)(F)F)C#N |
| PubChem CID | 132220479 |
| 分子量 | 471.44 |
| 溶解性 | DMSO : 62.5 mg/mL (132.57 mM; Need ultrasonic) |
|---|---|
| 分子量 | 471.400 g/mol |
| XLogP3 | 1.600 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 9 |
| 可旋转键计数Rotatable Bond Count | 2 |
| 精确质量Exact Mass | 471.163 Da |
| 单同位素质量Monoisotopic Mass | 471.163 Da |
| 拓扑极表面积Topological Polar Surface Area | 121.000 Ų |
| 重原子数Heavy Atom Count | 34 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 872.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |